Europe edition, free version

View this email online 

 
 

The Wire

Private equity deal news and insights from the London newsroom

Mar 11, 2025

 

Archimed buys another diagnostics business; EQT names private capital co-heads; HIG Capital in action

Morning all, Craig McGlashan here with the Europe Wire from the London newsroom.

 

We’ve got an exclusive interview to start the day, as we speak to Vincent Guillaumot, managing partner at Archimed, about his firm’s latest acquisition, announced this morning: BioVendor.

 

Next, we’ve got news of some new promotions at EQT, as the firm names a pair of private capital co-heads to replace Per Franzén, who is becoming CEO. We’ve also got some comment on the moves from chief commercial officer Suzanne Donohoe, who spoke about them at PEI Group’s NEXUS 2025 summit in Orlando.

 

On that subject, just a quick reminder that PE Hub Editor-in-Chief MK Flynn ([email protected]) and reporter Rafael Canton ([email protected]) are there. Make sure to drop them a note if you want a chat. You can also see our latest coverage from the event here.

 

Finally, we’ve got a couple of deals from HIG Capital to report. One in the technical consulting sector, and the other in industrial services.

 

‘Solid portfolio’

Archimed sees opportunities in the diagnostics sector amid changing regulations and potential tariff threats, Vincent Guillaumot, managing partner, told PE Hub in an exclusive interview about the firm’s new acquisition in the sector, announced this morning: BioVendor.

 

Read the premium Wire for more on the company and to learn how Archimed sees regulatory changes and tariffs affecting the sector.

 

Succession

EQT has appointed new co-heads of private capital, following last month’s appointment of Per Franzén as CEO.

 

Full details, as well as comment from chief commercial officer Suzanne Donohoe, are in the premium version of the Wire.

 

Double deal

It’s been a busy few days for HIG Capital. The firm announced today that it has acquired a majority stake in Protos, an independent technical consulting business, in partnership with the company’s management.

 

Earlier, a new affiliate of HIG-backed Rainham Industrial Services bought TEi out of administration.

 

Read more on both deals in the premium version of the Wire.

 

Right, that’s it from me. Michael Schoeck is in the US chair later today, where he’ll feature some fresh coverage from NEXUS. I’ll be back with you from Europe tomorrow.

 

Cheers,

Craig

 

Read the full Wire commentary on PE Hub ...

Today's must reads

> Archimed plans to make BioVendor a European player in diagnostics More...
> M&A forecast is partly cloudy, chance of rain now, but bright sunshine is coming soon, says Riverside's Stewart Kohl More...
> EQT’s Suzanne Donohoe: 'Investors need to be selective where they deploy capital' More...
> 'Talk to me, Goose!' LPs want more consistency in the way GPs share information More...
> Intra-European healthcare deals in vogue as PE seeks risk diversification More...

Also of note (may require subscriptions)

 

GPs get hands-on with secondaries: As traditional private equity houses enter the secondaries market en masse, more GPs are building up their capabilities to run ‘DIY’ continuation vehicle processes in-house. (Secondaries)

 

HSBC Life eyes rise in its infra allocation: Global CIO William Chan expects to see more favourable Hong Kong capital treatment of infra equity, which may spark up to $8bn of inflows from local insurers like HSBC Life. (Infrastructure Investor)

 

‘It’s a risk; not the risk’: Oregon mulls best route to net zero. Consultant, staff suggest council shouldn’t gamble on significant re-shuffle to meet strict emissions deadlines as the system mulls climate risk. (New Private Markets)

 

Fidelis Investors enters the RTL deal pipeline: Launched with Morningstar’s blessing, the firm’s February securitisation has 435 underlying loans. (Private Debt Investor)

 

BII launches $75m facility to boost climate-smart agriculture in Pakistan: British International Investment’s partnership with Pakistani bank HBL comes amid its broader push to invest £500m in climate finance by 2026. (Agri Investor)

Deals

> Keensight-backed Inherent adds on Conexio Telecom More...
> HIG Capital picks up controlling stake in Italy’s Protos More...
> Archimed plans to make BioVendor a European player in diagnostics More...
> TJC-backed PSC Group snaps up 32 Rescar operations More...
> PE-backed Clario to acquire WCG's electronic clinical outcome assessments business More...
> Imperial Capital-backed Skyline Roofing Partners acquires Classic Roofing & Construction and John Hogan Roofing More...
People
> EQT appoints new private capital co-heads amid CEO change More...
> Actis promotes Rahul Agrawal to partner More...
> GHK Capital-backed JohnsByrne president/CEO Corey Gustafson to retire More...

They said it

“BioVendor’s diverse product range is very well adapted to the consolidation play in medical labs in Europe.”

— Vincent Guillaumot, managing partner, Archimed

 

Today's letter was prepared by Craig McGlashan

Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article.

FIND OUT MORE
 

London | New York | Hong Kong | Tokyo | Sydney

PEI Group Ltd is registered in England no.6135779

Registered office: 5th Floor, 100 Wood Street, EC2V 7AN

LinkedInTwitter
 

To update your PE Hub email preferences, or to unsubscribe, click here.